分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

CHML promotes liver cancer metastasis by facilitating Rab14 recycle

Chen Tian-Wei, Yin Fen-Fen, Yuan Yan-Mei, Guan Dong-Xian, Zhang Erbin, Zhang Feng-Kun, Jiang Hao, Ma Ning, Wang Jing-Jing, Ni Qian-Zhi, Qiu Lin, Feng Jing, Zhang Xue-Li, Bao Ying, Wang Kang, Cheng Sh

Journal:Nature Communications

IF:11.88

DOI:10.1038/s41467-019-10364-0

PMID:

Published:2019-06-07

research field:肿瘤学分子生物学细胞生物学

Abstract

Metastasis-associated recurrence is the major cause of poor prognosis in hepatocellular carcinoma (HCC), however, the underlying mechanisms remain largely elusive. In this study, we report that expression of choroideremia-like (CHML) is increased in HCC, associated with poor survival, early recurrence and more satellite nodules in HCC patients. CHML promotes migration, invasion and metastasis of HCC cells, in a Rab14-dependent manner. Mechanism study reveals that CHML facilitates constant recycling of Rab14 by escorting Rab14 to the membrane. Furthermore, we identify several metastasis regulators as cargoes carried by Rab14-positive vesicles, including Mucin13 and CD44, which may contribute to metastasis-promoting effects of CHML. Altogether, our data establish CHML as a potential promoter of HCC metastasis, and the CHML-Rab14 axis may be a promising therapeutic target for HCC. Metastasis-associated recurrence is a major cause of poor prognosis in hepatocellular carcinoma. Here, the authors show that expression of choroideremia-like (CHML) is elevated and associates with poor prognosis in hepatocellular carcinoma, and mechanistically CHML promotes metastasis in a Rab14-dependent manner.

本文使用的Yeasen产品

购物车
客服
转染试用